https://www.selleckchem.com/pr....oducts/eidd-1931.htm
In the sRCC sub-group vs. the ITT population, pooled estimates of the PFS-HRs were 0.57 (95% 0.45-0.74) vs. 0.79 (95% CI 0.70-0.89), respectively, with a statistically meaningful interaction favoring the sRCC sub-group (pooled ratio of the PFS-HRs = 0.64; 95% CI 0.50-0.82; p less then 0.001). Pooled estimates of the difference in CR-R (complete response-rate) achieved with anti-PD-1/PDL-1 agents vs. sunitinib were + 0.10 (95% CI 0.04-0.16) vs. + 0.04 (95% CI 0.00-0.07) in the sRCC vs. the non-sRCC sub groups, with a statistically mean
Gefällt mir
Kommentar
Teilen
